Hong Kong Stock Movement | Alebund Pharmaceuticals-B (09637.HK) Surges Over 10% in Early Trading; Partner R1 Presented AP306 Global Phase IIb Multi-Regional Clinical Trial Design Poster at ASN Kidney Week

date
27/10/2026
Zhitong Finance APP has learned that Alebund Pharmaceuticals-B (09637.HK) rose more than 10% in early trading. As of press time, it was up 8.21% at HK$17.26, with a turnover of HK$10.8661 million.